Human Immunoglobulin (IVIG)

About Shanghai RAAS Blood Products

Shanghai RAAS Blood Products is a critical enterprise in China's national biopharmaceutical strategy, focusing on ensuring the supply and safety of plasma-derived therapies. The company operates numerous plasma collection stations and has a vertically integrated manufacturing platform, positioning it as a dominant force in a market with significant barriers to entry. Its strategic direction involves expanding its plasma fractionation capacity, advancing its recombinant protein pipeline, and leveraging its scale to meet growing domestic demand for essential blood products.

About Tiantan Bio

Tiantan Bio is a major player in China's biopharmaceutical sector, with a core focus on plasma-derived therapeutics and vaccines. As part of the Sinopharm Group ecosystem, it benefits from significant scale and strategic importance in public health. The company leverages its extensive plasma collection network and manufacturing capabilities to serve the large domestic market, with a pipeline that includes both biosimilars and novel biological products.

About Hualan Biological Engineering

Hualan Biological Engineering is a prominent, vertically integrated vaccine and blood product manufacturer in China, with a significant market share in influenza vaccines. The company leverages its established production capabilities and extensive distribution network to serve the domestic public health market. Its strategic focus includes expanding its vaccine portfolio, advancing its plasma fractionation business, and pursuing international market opportunities. As a publicly traded entity, it plays a key role in China's national immunization programs and biosecurity strategy.

Therapeutic Areas